Preferred Label : mupirocin;

MeSH definition : A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.;

MeSH synonym : pseudomonic acid a;

CISMeF synonym : acid, pseudomonic; pseudomonic acid;

MeSH hyponym : Mupirocin, Calcium Salt (2:1); Mupirocin, Calcium Salt (2:1), Dihydrate; mupirocin, 14C-Labeled; mupirocin, sodium salt; BRL-4910A; mupirocin, lithium salt; bactroban; BRL 4910A; BRL4910A; 14C-Labeled Mupirocin; Mupirocin, 14C Labeled;

MeSH CAS label : nonanoic acid, 9-((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-, (2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))-;

MeSH Related Number : mupirocin, 14C-Labeled; mupirocin, sodium salt; mupirocin, calcium salt (2:1), dihydrate; mupirocin, lithium salt; mupirocin, calcium salt (2:1); 104486-81-9 (Ca(2:1) salt(2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))); 115074-43-6 (Ca(2:1) dihydrate salt (2S-(2alpha(E),3beta,5alpha(2R*,3R*(1R*,2R*))))); 12650-69-0 (Mupirocin); 64838-37-5 (Na salt); 73346-79-9 (Li salt(2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))); 85617-79-4 (2-(14C-labeled(2S-2alpha(e),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))); RG38I2P540;

Registry Number MeSH : 12650-69-0;

Related CAS MeSH : 85617-79-4 (Mupirocin, 14C-Labeled); 64838-37-5 (Mupirocin, sodium salt); 115074-43-6 (Mupirocin, calcium salt (2:1), dihydrate); 73346-79-9 (Mupirocin, lithium salt); 104486-81-9 (Mupirocin, calcium salt (2:1));

Wikipedia link : https://en.wikipedia.org/wiki/Mupirocin;

Is substance : O;

UNII : D0GX863OA5;

InChIKey : MINDHVHHQZYEEK-HBBNESRFSA-N;

Details


Main resources

You can consult :

A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.

https://www.has-sante.fr/portail/jcms/c_2894929/en/mupiderm
2018
true
France
French
antibiotic therapy
mupirocin
administration, cutaneous
anti-bacterial agents
insurance, health, reimbursement
mupirocin
impetigo
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2752329/fr/bactroban
2017
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
mupirocin

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=68172597
2016
false
false
false
France
French
summary of product characteristics
package leaflet
administration, cutaneous
drugs, generic
mupirocin
mupirocin
ointments
skin diseases, bacterial
staphylococcal skin infections
streptococcal infections
anti-bacterial agents

---
http://unt-ori2.crihan.fr/unspf/2014_Rennes_Tomasi_Antibacteriens-divers
2015
false
true
true
France
French
educational course
fosfomycin
mupirocin
education, pharmacy
mupirocin
mupirocin
mupirocin
fosfomycin
fosfomycin
fosfomycin
fusidic acid
fusidic acid
fusidic acid
fusidic acid
fusidic acid
anti-bacterial agents

---
http://www.has-sante.fr/portail/jcms/c_1768786/fr/mupiderm
http://www.has-sante.fr/portail/jcms/c_722943/mupiderm
2014
false
France
French
antibiotic therapy
mupirocin
administration, cutaneous
anti-bacterial agents
insurance, health, reimbursement
mupirocin
impetigo
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1221576/bactroban
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/bactroban_15022012_avis_ct11658.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_459735
2012
France
French
secondary prevention
antibiotic therapy
mupirocin
anti-bacterial agents
ointments
administration, intranasal
insurance, health, reimbursement
staphylococcus aureus
staphylococcal skin infections
staphylococcal infections
adult
child
treatment outcome
renal dialysis
mupirocin
evaluation of the transparency committee

---
http://www.cochrane.org/fr/CD006216
2011
United Kingdom
France
French
antibiotic therapy
french abstract
meta-analysis
staphylococcus aureus
staphylococcal infections
treatment outcome
carrier state
ointments
mupirocin
anti-bacterial agents
nose

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66325311
2008
France
French
antibiotic therapy
anti-bacterial agents
protein synthesis inhibitors
administration, intranasal
ointments
mupirocin
mupirocin
anti-bacterial agents
drug approval
drug labeling
staphylococcal skin infections
staphylococcus aureus
staphylococcal infections
adult
child
protein synthesis inhibitors
mupirocin
summary of product characteristics
package leaflet

---
Nous contacter.
28/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.